Guideline History
Sort and Filter
- Submit
- Reset
19/04/2024
Consumer information: Instrumental vaginal birth
C24.49-1-V5-R29
- Following full review
19/04/2024
Education presentation: Instrumental vaginal birth
E24.49-1-V3-R29
- Following full review
19/04/2024
Guideline and supplement: Instrumental vaginal birth
MN24.49-V3-R29
- Following full review
19/04/2024
Education presentation: Preconception and prenatal genetic screening
E24.36-1-V1-R29
- First publication
19/04/2024
Flowchart Preconception reproductive genetic carrier screening
F24.36-1-V1-R29
- First publication
19/04/2024
Flowchart Reproductive genetic carrier screening during pregnancy
F24.36-2-V1-R29
- First publication
19/04/2024
Flowchart Chromosome condition screening during pregnancy
F24.36-3-V1-R29
- First publication
19/04/2024
Guideline and Supplement: Preconception and prenatal genetic screening
MN24.36-V1-R29
- First publication
19/04/2024
Flowchart: Management of women with Rh D negative blood group (including NIPA)
F23.74-2-V2-R28
- Amended: - termination of pregnancy before 10+0 weeks (medical or surgical) no longer identified as a sensitising event requiring Rh D immunoglobulin
19/04/2024
Flowchart: Management of women with Rh D negative blood group (excluding NIPA)
F23.74-1-V2-R28
- Amended: - termination of pregnancy before 10+0 weeks (medical or surgical) no longer identified as a sensitising event requiring Rh D immunoglobulin
19/04/2024
Education presentation Rh D negative women in pregnancy
E23.74-1-V2-R28
- Amended: - termination of pregnancy before 10+0 weeks (medical or surgical) no longer identified as a sensitising event requiring Rh D immunoglobulin
19/04/2024
Guideline and supplement: Rh D negative women in pregnancy
MN23.74-V2-R28
- Amended: Termination of pregnancy before 10+0 weeks (medical or surgical) no longer identified as a sensitising event requiring Rh D immunoglobulin
04/04/2024
Perinatal mental health
E24.76-1-V1-R29
- First publication of education presentation to accompany the Perinatal mental health clinical guideline
04/04/2024
Perinatal mental health
F24.76-1-V1-R29
- First publication of flowchart to accompany the Perinatal mental health clinical guideline
04/04/2024
Perinatal mental health
MN24.76-V1-R29
- First publication of Perinatal mental health clinical guideline and supplement
04/04/2024
Neonatal medicine monograph hydralazine hydrochloride
NMedQ24.111-V1-R29
- First publication of neonatal medicine monograph hydralazine hydrochloride
25/03/2024
Neonatal medicine monograph phosphate
NMedQ22.087-V2-R27
- Deleted: compound oral solution is no longer available and was deleted
25/03/2024
Neonatal medicine monograph vitamin D
NMedQ22.075-V2-R27
- Amendment: dosage for neonatal deficiency added
25/03/2024
Neonatal medicine monograph phenobarbital
NMedQ21.062-V2-R26
- Amendment: duration of IV administration (infusion and injection) added
25/03/2024
Neonatal medicine monograph isradipine
NMedQ24.113-V1-R29
- First publication of the neonatal medicine monograph isradipine
25/03/2024
Neonatal medicine monograph sprionolactone
NMedQ24.112-V1-R29
- First publication of the neonatal medicine monograph spironolactone
29/02/2024
Working party list for Newborn bloodspot screening
WP24-53-1-V1-R29
- List of working party members for the Newborn bloodspot screening guideline
29/02/2024
Parent information Perineal care
C23-30-1-V5-R28
- "Your perineum and having a baby" parent information to accompany the Perineal care clinical guideline
29/02/2024
Parent information Perineal care
C23-30-2-V6-R28
- "Third and fourth degree tears" parent information to accompany the Perineal care clinical guideline
25/01/2024
Neonatal medicine monograph benzyl-penicillin
NMedQ20.013-V5-R25
- Added: definition of current gestational age
- Amended: instructions for dose frequency to clarify frequency alters as baby ages
- Added: duration of dosage for congenital syphilis
25/01/2024
Neonatal medicine monograph albumin
NMedQ20.048-V2-R25
- Amendment: added albumin 5% for Australian transition from 4% to 5% albumin
- Updated: albumen 20% product name and storage conditions
25/01/2024
Neonatal medicine monograph morphine sulfate
NMedQ20.032-V2-R25
- Amendment: Added to special considerations: "If prescribed as premedication for elective intubation, wait at least 5 minutes (5–15 minutes) for onset of action before administration of subsequent medications"
- Removed: UAC icon and amended instructions for administration via UAC
22/12/2023
Term prelabour rupture of membranes (PROM-Term)
C23.47-1-V2-R28
- Publication of consumer information to accompany the peer review of guideline and supplement
22/12/2023
Term prelabour rupture of membranes (PROM-Term)
E23.47-1-V3-R28
- Publication of education to accompany the peer review of guideline and supplement
22/12/2023
Term prelabour rupture of membranes (PROM-Term)
MN23.47-V2-R28
- Publication of of guideline and supplement following peer review
22/12/2023
Preterm prelabour rupture of membranes (PPROM)
MN23.48-V3-R28
- Publication of guideline and supplement following peer review
22/12/2023
Preterm prelabour rupture of membranes (PPROM)
E23.48-V3-R28
- Publication of education to accompany the peer review of guideline and supplement
22/12/2023
Preterm prelabour rupture of membranes (PPROM)
C23.48-1-V3-R28
- Publication of consumer information to accompany the peer review of guideline and supplement
22/12/2023
Perineal care
MN23.30-V5-R28
- Publication of guideline and supplement following peer review
22/12/2023
Perineal care
E23.30-1-V4-R28
- Publication of education to accompany the peer review of the perineal care clinical guideline
22/12/2023
Neonatal medicine monograph Indometacin
NMedQ23.104-V1-R28
- First publication of the neonatal medicine Indometacin
11/12/2023
Neonatal medicine monograph Glucose gel
NMedQ19.020-V2-R24
- Amendment: Added indication and dose for prophylactic use and a quick guide for dose by weight calculation
30/11/2023
Stabilisation for retrieval-neonatal
E23.18-1-V6-R28
- Publication: Education presentation to accompany stabilisation for retrieval clinical guideline and supplement
30/11/2023
Stabilisation for retrieval-neonatal
C23.8-1-V5-R28
- Publication: Consumer information to accompany stabilisation for retrieval clinical guideline and supplement
30/11/2023
Stabilisation for retrieval-neonatal
MN23.18-V5-R28
- Publication: Peer review of guideline and supplement
30/11/2023
Hypoglycaemia - newborn
C23.8-1-V5-R28
- Publication: Consumer information to accompany the hypoglycaemia -newborn clinical guideline
30/11/2023
Hypoglycaemia - newborn
E23.8-1-V6-R28
- Publication: Education presentation to accompany the full review of the hypoglycaemia -newborn clinical guideline
30/11/2023
Hypoglycaemia - newborn
MN23.8-V13-R28
- Published: Full review of clinical guideline and supplement
07/11/2023
Stillbirth care
MN23.24-V10-R28
- Amendment: Updated reference to QLD Maternal and Perinatal Quality Council report
- Amendment: Updated reference to Hospital and Health Services Act
06/10/2023
Termination of pregnancy
Ed19.21-1-V6-R24
- Amendment: Updated to align with guideline MN19.21-V9-24. Minor wording about capacity to consent
06/10/2023
Termination of pregnancy
F19.21-2-V5-R24
- Amendment: Updated to align with guideline MN19.21-V9-24. Requirement for prescriber education for MS-2 Step removed
06/10/2023
Termination of pregnancy
MN19.21-V9-R24
- Amendment: Removed requirements for MS-2 Step prescriber education as per TGA
- Amendment: Section 5.4 Fetal considerations - new section (section 5.4.3 Born with signs of life) inserted
- Amendment: Section 5.3 MToP and SToP risks and complications - Live birth added
29/09/2023
Stillbirth care
E23.24-1-V8-R28
- Publication of education presentation to accompany the Stillbirth care guideline
29/09/2023
Stillbirth care
C23.24-2-V7-R28
- Publication of consumer information 'Autopsy examination of a baby' to accompany the Stillbirth care guideline
29/09/2023
Stillbirth care
C23.24-1-V7-R28
- Publication of consumer information 'What to expect after the loss of your baby' to accompany the Stillbirth care guideline
29/09/2023
Stillbirth care
C23.24-3-V3-R28
- Publication of consumer information 'Grief after your baby dies' to accompany the Stillbirth care guideline
29/09/2023
Stillbirth care
MN23.24-V9-R28
- Publication of Stillbirth care clinical guideline and supplement following Peer Review
22/09/2023
Neonatal medicine miconazole
NMedQ23.107-V1-R28
- First publication of neonatal medicine miconazole
22/09/2023
Neonatal medicine glycerol
NMedQ23.108-V1-R28
- First publication of neonatal medicine glycerol
22/09/2023
Neonatal medicine microlax
NMedQ23.103-V1-R28
- First publication of neonatal medicine microlax
22/09/2023
Neonatal medicine nystatin
NMedQ23.100-V1-R28
- First publication of neonatal medicine nystatin
18/09/2023
Instrumental vaginal birth
MN18.49-V2-R23
- Review date extended until Dec 2024. No change to content
18/09/2023
Perineal care
MN18.30-V4-R23
- Review date extended until Dec 2024. No change to content
18/09/2023
Primary postpartum haemorrhage
MN18.1-V10-R23
- Review date extended until Dec 2024. No change to content
18/09/2023
Syphilis in pregnancy
MN18.44-V6-R23
- Review date extended until Dec 2024. No change to content
25/08/2023
Syphilis in pregnancy
MN18.44-V6-R23
- Amendment: To align with QMPQC recommendations for routine antenatal screening at 36 weeks
31/07/2023
Fetal movements
MN23.46-V3-R28
- Peer review
- Formatting and references updated
18/07/2023
Normal birth
MN22.25-V5-R27
- Amendments to Section 2.1 Continuity of care: Statistical analysis in Tables 4 and 5 amended from Absolute Risk Reduction/Absolute Benefit Increase to;Risk Ratio.
22/06/2023
Induction of labour
MN22-22-V9-R27
- Update: Statistics in Table 5, Table 6, Table 13 and Table 23 updated
- Addition to Flowchart: Oxytocin and Appendix D: Oxytocin regimen administration: Caution note and suggested maximum oxytocin dosage for use in women with previous uterine surgery added
15/06/2023
Establishing breastfeeding
MN21-19-V5-R26
- Amendment: Section 6. Recommended time frame to express breasts if baby unable to initiate breastfeeding or is separated from mother-changed from within six hours of birth, to within two hours of birth
- Amendment: Appendix D: Breast engorgement and mastitis spectrum sections updated
15/6/2023
Neonatal medicine dexmedetomidine
NMedQ23.101-V1-R28
- First publication of neonatal medicine dexmedetomidine
15/6/2023
Neonatal medicine trimethoprim with sulfamethoxazole
NMedQ23.106-V1-R28
- First publication of neonatal medicine trimethoprim with sulfamethoxazole
15/6/2023
Neonatal medicine heparin sodium
NMedQ23.102-V1-R28
- First publication of neonatal medicine heparin sodium
15/6/2023
Neonatal medicine omeprazole
NMedQ23.105-V1-R28
- First publication of neonatal medicine omeprazole
28/04/2023
Clinical form: Neonatal seizure and neurological observations
SW1209-V1
- First publication of clinical form for neonatal seizure and neurological observation
28/04/2023
Clinical form: Encephalopathy servity assessment and therapeutic cooling critiera
SW1208-V1
- First publication of clinical form for encephalopathy severity assessment and therapeutic hypothermia criteria
21/04/2023
Education presentation: Neonatal resuscitation
E22.5-1-V6-R27
- Amendment to education presentation to clarify chest compression techniques to be used if one or two person performing
21/04/2023
Working party list: Fetal movements
WP23.46-1-V2-R28
- List of working party members for review of fetal movements
21/04/2023
Education presentation: Rh D woman and pregnancy
E23.74-1-V1-R28
- New publication education presentation
21/04/2023
Consumer information: Rh D woman and pregnancy
C23.74-1-V1-R28
- New publication consumer information sheet
31/03/2023
Neonatal medicine benzylpenicillin
NMedQ20.013-V4-R25
- Amendment to align with ASID recommendations for term infants: Dosage for sepsis (IV and IM) for baby at 37+0 weeks or more current gestational age at 8 or more days of age FROM 60 mg/kg every 8 hours TO 60mg/kg every 6 hours.
31/03/2023
Neonatal medicine clonidine
NMedQ22.085-V2-R27
- Amendment: Preparation instructions for tablet use added
30/03/2023
Term small for gestational age baby
MN22-16-V6-R27
- Amendment: Correction Table 9. Estimate of growth restriction using Fenton growth charts - Female weight at 41+0 weeks gestation on 10th percentile FROM 3980 g TO 2980 g
30/03/2023
Retinopathy of prematurity consensus statement
O21.55-1-V2-R26
- Amendment: Added for further information refer to RANZCO guideline
30/03/2023
List of working party members for Stillbirth care review
WP23.24-1-V1-R28
- Working party members for Stillbirth care review
30/03/2023
Guideline: Rh D negative women and pregnancy
MN23.74-V1-R28
- New publication clinical guideline and supplement
10/03/2023
Consumer information: Breastfeeding and medicines
C23.19-2-V1-R28
- New publication to accompany breastfeeding clinical guideline
10/03/2023
Consumer information: Induction of labour (IOL)
C23.22-1-V4-R27
- Accompany IOL clinical guideline
10/03/2023
Consumer information: Induction of labour (IOL): Part 1 cervical ripening
C23.22-2-V1-R27
- New publication to accompany IOL clinical guideline
10/03/2023
Consumer information: Induction of labour (IOL): Part 2 rupturing your membranes and oxytocin
C23.22-3-V1-R27
- New publication to accompany IOL clinical guideline
28/02/2023
Guideline: Intrapartum pain management
MN23.75-V1-R28
- First publication of clinical guideline on intrapartum pain management and associated resources
- Incorporated existing 4 shortGuides on pharmacological analgesia (now rescinded)
28/02/2023
Neonatal medicine poloxamer 10%
NMedQ23.099-V1-R28
- First publication of neonatal medicine poloxamer 10%
28/02/2023
Neonatal medicine palivizumab
NMedQ23.098-V1-R28
- First publication of neonatal medicine palivizumab
28/02/2023
Neonatal medicine rasburicase
NMedQ23.097-V1-R28
- First publication of neonatal medicine rasburicase
28/02/2023
Neonatal medicine levothyroxine
NMedQ23.096-V1-R28
- First publication of neonatal medicine levothyroxine
15/02/2023
Guideline Stillbirth care
MN18.24-V8-R23
- Review date extended while review in progress. Nil other amendments
15/02/2023
Guideline Neonatal stabilisation for retrieval
MN18.18-V4-R23
- Review date extended while review in progress. Nil other amendments
06/02/2023
Eduction presentation Gestational diabetes mellitus
E21.33-1-V3-R26
- Amendment slide 23 Metformin: Maximum dose metformin: FROM 2500 mg standard release (SR) TO: Metformin 2500 mg intermediate release (IR)
06/02/2023
Neonatal medicine Adrenaline
NMedQ22.079-V4-R27
- Amendment: Added to ETT dose: volume equivalent in mL/kg
06/02/2023
Neonatal medicine Caffeine Citrate
NMedQ19.006-V2-R24
- Added to preparation instructions: prescribed dose greater than 0.5 mL (10 mg) may be given undiluted
- Added to special considerations: small dose volumes can be difficult to administer accurately to VLBW infants therefore diluted preparation is the preferred option in this cohort
- Added to signs of toxicity: tremors and tachypnoea
- Added QR code
- Deleted UAC icon: wording amended about administration via UAC
- Minor referencing updates
16/01/2023
Neonatal medicine Vancomycin
NMedQ23.094-V1-R28
- First publication of neonatal medicine vancomycin
16/01/2023
Neonatal medicine Valganciclovir
NMedQ23.093-V1-R28
- First publication of neonatal medicine valganciclovir
16/01/2023
Neonatal medicine Ganciclovir
NMedQ23.092-V1-R28
- First publication of neonatal medicine ganciclovir
16/01/2023
Neonatal medicine Fluconazole
NMedQ23.095-V1-R28
- First publication of neonatal medicine fluconazole
03/01/2023
Neonatal medicine Adrenaline
NMedQ22.079-V3-R27
- Amendment: Correction to IV infusion preparation instructions. FROM: Draw up 0.3 mg/kg (0.3 mL/kg of 1:10,000) TO: Draw up 0.3 mg/kg (3 mL/kg of 1:10,000)s
21/12/2022
Termination of pregnancy
MN19.21-V8-R24
- Amendment: For MS-2 Step: FROM undertake routine antenatal serum screening. TO: If MToP with MS-2 Step, routine antenatal serum screening not required, consider based on history/opportunistically with other serum tests
21/12/2022
Neonatal jaundice
MN22.7-V9-R27
- Full Review
- Removed: Elements of care relevant to QCG 'Standard care' clinical guideline
- Removed: Nomograms referenced to QCG 'Nomograms for jaundice phototherapy and exchange transfusion'
21/12/2022
Neonatal seizures
MN22.23-V4-R27
- Full Review
- Removed: Elements of care relevant to QCG 'Standard care' clinical guideline
- Removed: Drug regimens referenced to QCG 'NeoMedQ neonatal medicine monographs'
- Updated: Classification of seizures as per International League of Epilepsy
21/12/2022
Induction of labour
MN22.22-V8-R27
- Full Review
- Expanded: Guidance on communication and decision making, timing of birth, risks and benefits of IOL compared with expectant management, setting for cervical ripening
- Updated: prolonged pregnancy, suspected fetal macrosomia, intrahepatic cholestasis, advanced maternal age, transcervical balloon catheter
21/12/2022
Normal birth
MN22.25-V4-R27
- Full Review
- Removed: Elements of care relevant to 'Standard care' clinical guideline
- Transferred to 'Intrapartum pain management' clinical guideline: Pharmacological and non pharmacological support including water immersion, and nitrous oxide and oxygen
05/12/2022
Preterm labour and birth
MN20.06-V10-R25
- Flowchart MgSO4: Amendment - loading dose aligned with text FROM over 15 minutes | TO over 20 minutes
- Table 2. Risk factors associated with preterm birth: Addition - risk of PTB based on ethnicity
- Table 3 Risk reduction measures: Addition - recommendation for universal routine cervical length measurement during mid-trimester ultrasound
- Section 3.1 Progesterone therapy: Amendment - recommendation strengthened FROM Consider prophylactic progesterone | TO Recommend vaginal progesterone from 16-36 weeks if incidentally diagnosed shortened cervix or prior spontaneous preterm birth between 20–34 weeks
- Section 3.2 Cervical cerclage: Addition - consider cervical cerclage for women with cervical length less than 10 mm
- Section 5.4 Antenatal corticosteroids: Amendment - recommendations aligned with QCG guideline: Antenatal corticosteroids
25/11/2022
Standard care
MN22.50-V2-R27
- Guideline and supplement (Full Review)
22/11/2022
Pain and bleeding in early pregnancy
C22.29-2-V4-R27
- New publication: Consumer information to accompany the Early pregnancy loss clinical guideline
22/11/2022
Having a miscarriage
C22.29-4-V1-R27
- New publication: Consumer information to accompany the Early pregnancy loss clinical guideline
22/11/2022
Ectopic pregnancy
C22.29-1-V2-R27
- New publication: Consumer information to accompany the Early pregnancy loss clinical guideline
22/11/2022
Methotrexate for ectopic pregnancy
C22.29-5-V1-R27
- New publication: Consumer information to accompany the Early pregnancy loss clinical guideline
11/11/2022
Neonatal resuscitation checklist
F22.5-3-V3-R27
- Amendment: Added additional equipment when humidification required (adaptor 15m/10f-10m neonatal; humidification T-piece circuit;humidifer chamber; sterile water for injection 1L bag)
09/11/2022
Hypoxic ischaemic encephalopathy
MN21.11-V11-R26
- Amendment: Table 6 HIE staging, to align with Flowchart Assessing baby for therapeutic hypothermia FROM: If three or more signs of moderate or severe HIE or seizures at any time in first six hours consult with neonatologist regarding commencing TH. TO: If two or more signs of moderate or severe HIE or seizures at any time in first six hours consult with neonatologist regarding commencing TH
09/11/2022
Termination of pregnancy
MN19.21-V7-R24
- Amendment: Rh D immunoglobulin no longer recommended for MToP before 10+0 weeks gestation
- Amendment: Recommendation for prophylactic antibiotics for MToP changed FROM: Insufficient evidence to recommend the use of antibiotics prior to MToP TO: Prophylactic antibiotics not recommended for MToP
- Added: Information when counselling women about the potential for live birth
28/10/2022
Syphilis in pregnancy
MN18.44-V5-R23
- Amendment: Universal screening at 28 weeks gestation recommended
14/10/2022
Early pregnancy loss
MN22.29-V6-R27
- Guideline and associated resources: Peer review
14/10/2022
Neonatal resuscitation
MN22.5-V6-R27
- Guideline and associated resources: Peer review
26/09/2022
Neonatal medicine pyridoxine
NMedQ22.089-V1-R27
- First publication neonatal medicine pyridoxine
26/09/2022
Neonatal medicine phenytoin
NMedQ22.090-V1-R27
- First publication neonatal medicine phenytoin
26/09/2022
Neonatal medicine lidocaine
NMedQ22.091-V1-R27
- First publication neonatal medicine lidocaine
26/09/2022
Neonatal medicine clonazepam
NMedQ22.088-V1-R27
- First publication neonatal medicine clonazepam
21/09/2022
Adult inpatient management of steroid induced hyperglycaemia
ACG22.73-1-V1-R27
- First publication (in collaboration with Queensland Diabetes Clinical Network)
09/08/2022
Early onset Group B Streptococcal disease
MN22.20-V6-R27
- Flowchart: Neonatal management of early onset Group B Streptococcal disease (EOGBSD) updated to reflect text
- Section 2 Risk factors: FROM another baby of multiple | TO other baby of multiple
- Section 5.2 Criteria for investigation of sepsis: increased observation – removal of preterm labour at less than 37+0 weeks
- Section 5.2 Criteria for investigation of sepsis: increased observation – addition of guidance for monitoring newborn with sibling currently treated for GBS infection
- Section 5.4 Antibiotic therapy: FROM treatment of GBS meningitis for diagnosed infection | TO guidance for treatment of both confirmed and suspected GBS meningitis
02/08/2022
Aciclovir
NMedQ19.10-V3.R24
- Amendment to preparation instructions: powdered vial no longer available
29/07/2022
Safer infant sleep
MN22.71-V1-R27
- First publication (in collaboration with QLD Paediatric Quality Council)
29/07/2022
Early onset Group B Streptococcal disease
MN22.20-V5-R27
- Peer Review: Risk factor approach re-endorsed
26/07/2022
Neonatal medicine adrenaline (epinephrine)
NMedQ22.079-V2-R27
- Amendment: to align with ANZCOR recommendation for rapid IV bolus during resuscitation. FROM: Adrenalin every 2–3 minutes TO: Adrenaline every 3–5 minutes
26/07/2022
Neonatal medicine phosphate
NMedQ22.087-V1-R27
- First publication neonatal medicine phosphate
26/07/2022
Neonatal medicine magnesium sulfate
NMedQ22.086-V1-R27
- First publication neonatal medicine magnesium sulfate
26/07/2022
Neonatal medicine clonidine
NMedQ22.085-V1-R27
- First publication neonatal medicine clonidine
26/07/2022
Neonatal medicine azithromycin
NMedQ22.084-V1-R27
- First publication neonatal medicine azithromycin
26/07/2022
Neonatal medicine argipressin (vasopressin)
NMedQ22.083-V1-R27
- First publication neonatal medicine argipressin
14/06/2022
Hypoglycaemia - newborn
MN19.8-V12-R24
- Amendments Flowchart 3: Management of neonatal hypoglycaemia (baby symptomatic or BGL 1.5 mmol/L
- Renamed TO Management of BGL less than 1.5 mmol/L or baby symptomatic,
- Amended criteria for commencement of weaning IV therapy to align with document text
- FROM BGL 2.6 mmol/L for more than 12 hours
- TO BGL 3.0 mmol/L for more than 12 hours.
- Duplicate label on outflow amended FROM yes TO no
- Urgent treatment:
- FROM If asymptomatic or mild symptoms: Administer IV 10% glucose bolus, Consider glucose gel 40% and breastfeed in addition, Commence 10% glucose infusion at 60 mL/kg, Give glucagon IM or subcut if IV access delayed by more than 15 minutes -If symptomatic or BGL not improving: Give glucagon IV (IM or subcut if IV access delayed by more than 15 minutes), Commence 10% glucose infusion at 80 mL/kg
- TO Commence 10% glucose infusion at 60 mL/kg/day, If symptomatic or BGL not improving commence at 80 mL/kg/day; Give 10% glucose 1–2 mL/kg IV bolus Consider glucose gel 40% and breastfeed, Recheck BGL after 30 minutes, If BGL improving, continue 10% glucose IV adjust as needed, If symptomatic or BGL not improving give glucagon IV, Repeat BGL after 30 minutes and if required, repeat glucose bolus and glucagon, If IV access delayed > 15 minutes give glucagon IM or subcut.
- Added to Definitions: enteral feeding
- Table 5 Screening:
- Last row split into two rows (new row: Validate BGL less than 2.6 mmol/L) no content change
- Table 8: Initial management (first 48 hours of life)
- References to NeoMedQ monographs rationalised to top of page
- Third row (BGL less than 1.5 mmol/L or unrecordable) spilt into two rows (new row Difficult IV access) no content change
- Last row: (Ceasing BGL monitoring) moved to new table: Ceasing BGL monitoring
- Table 11: BGL monitoring First row (BGL)
- Split into 5 rows (no content change)
- Last row (Ceasing BGL monitoring) moved to new table: Ceasing BGL monitoring
- Table 12: Ceasing BGL monitoring
- New table from content in Table 8 and Table 11
- Correction to criteria for ceasing after 48 hours
- FROM 3 mmol/L TO 3.3 mmol/L
- Subsequent table numbering increased by 1
- Table 15: Medications
- References updated to relevant NeoMedQ medicine monographs only
- Minor formatting corrections throughout
19/05/2022
Gestational diabetes mellitus
MN21.33-V7-R26
- Flowchart: Screening and diagnosis of GDM - amended: information from guideline (Table 16 Self-monitoring) about fasting BGL and commencement of pre- and postprandial self-monitoring (when OGTT not suitable)
19/05/2022
Neonatal medicine topiramate
NMedQ21.067-V2-R26
- Deleted from special considerations “if therapeutic hypothermia refer to QCG Neonatal seizures guideline”
16/05/2022
Neonatal Seizures
MN17.23-V3-R22
- Review date extended FROM May 2022 TO May 2023
16/05/2022
Early pregnancy loss
MN17.29-V5-R22
- Review date extended FROM May 2022 TO May 2023
16/05/2022
Induction of labour
MN17.22-V7-R22
- Review date extended FROM March 2022 TO March 2023
16/05/2022
Gestational diabetes mellitus
MN21.33-V6-R26
- Flowchart: Screening and diagnosis of GDM - added: information from guideline (Table 16 Self-monitoring) for suggested target BGLs when self-monitoring
- Flowchart Screening and diagnosis of GDM and Tables 8 and 14: - FROM: ‘evidence of fetal hyperinsulinaemia on growth USS’. TO: ‘evidence of excess fetal growth/adiposity on growth USS’
- Table 20 Metformin FROM: Maximum dose: 2500mg (SR) TO: Maximum dose: 2500mg (immediate release) (no dose change)
29/04/2022
Statewide nomograms forms (all)
SW1106 to SW1111 (V2)
- Update (all): additional fields to capture start and end time of phototherapy
29/04/2022
Maternity care for mothers and babies during the COVID-19 pandemic
MN21.063-V12-R26
- Guideline, supplement and flowchart: Updated information about close contact management. Update to COVID-19 vaccination intervals after positive COVID-19 result.
21/04/2022
Neonatal medicine vitamin D
NMedQ22.075-V2-R27
- Added: information if receiving low birth weight formula or human milk fortifier and commencement if no previous pentavite.
21/04/2022
Preterm prelabour rupture of membranes (PPROM)
MN18.48-V2-R23
- Guideline and education: Recommended antibiotics for PPROM updated and aligned with Therapeutic Guidelines.
25/03/2022
Hypoglycaemia - newborn
MN19.8-V11-R24
- Guideline and flowchart: Treatment recommendations for symptomatic baby or BSL less than 1.5 mmol/L with glucagon and glucose amended at Section 4.2, Section 4.5.1, and flowchart management of neonatal hypoglycaemia (baby symptomatic or BGL less than 1.5 mmol/L).
25/03/2022
Term small for gestational age newborn baby
MN22.16-V6-R27
- Guideline and associated resources: Full review
09/03/2022
Termination of pregnancy
MN19.21-V6-R24
- Guideline: Alignment with legislative amendments related to student health practitioner assisting with a termination
- Guideline: Alignment with legislative amendments related to child abuse (Criminal Code Act 1899)
09/03/2022
Maternity care for mothers and babies during COVID-19 pandemic
MN21.63-V11-R26
- Guideline: Neonatal flowchart updated to include close contact testing and isolation/quarantine requirements
- Guideline: Visitor restrictions to a neonatal unit specified
01/03/2022
Neonatal medicine metronidazole
NMedQ22.080-V1-R27
- First publication neonatal medicine metronidazole
01/03/2022
Neonatal medicine micafungin
NMedQ22.081-V1-R27
- First publication neonatal medicine micafungin
01/03/2022
Neonatal medicine omnipaque
NMedQ22.082-V1-R27
- First publication neonatal medicine omnipaque
01/03/2022
Neonatal medicine adrenaline
NMedQ22.079-V1-R27
- First publication neonatal medicine adrenaline
01/03/2022
Rheumatic heart disease and pregnancy
MN22.40-1-V1-R27
- First publication
16/02/2022
Neonatal medicine ceftriaxone
NeoMedQ21.068-V5-R26
- Added: Preparation instructions for IM 350 mg/mL final concentration
10/02/2022
Maternity care for mothers and babies during COVID-19 pandemic
MN21.63-V10-R26
- Guideline: Definition of a neonatal (baby) close contact amended
- Guideline: Visitor information updated
11/01/2022
Consumer role
O22.34-4-V3-R27
- Published Consumer representative role updated
11/01/2022
Neonatal medicine vitamin E
NMedQ22.076-V1-R27
- First publication neonatal medicine monograph vitamin E
11/01/2022
Neonatal medicine vitamin D
NMedQ22.075-V1-R27
- First publication neonatal medicine monograph vitamin D
11/01/2022
Neonatal medicine vitalipid N (infant)
NMedQ22.078-V1-R27
- First publication neonatal medicine monograph vitalipid N (infant)
11/01/2022
Neonatal medicine prednisolone
NMedQ22.074-V1-R27
- First publication neonatal medicine monograph prednisolone
11/01/2022
Neonatal medicine pentavite
NMedQ22.077-V1-R27
- First publication neonatal medicine monograph pentavite
07/01/2022
Maternity care for mothers and babies during COVID-19 pandemic
MN21.63-V9-R26
- Guideline: removed reference to patient transfer to designated hospital
05/01/2022
Maternity care for mothers and babies during COVID-19 pandemic
MN21.63-V8-R26
- Guideline, education presentation and consumer information: Added booster vaccination information, added omicron variant of concern
20/12/2021
Hypoxic ischaemic encephalopathy (HIE)
MN21.11-V10-R26
- Peer review and update of literature and references
20/12/2021
Maternity shared care operational framework
MN21.27-V3-R26
- Full review and update of literature and references
- Elements of Standard care removed
26/11/2021
Newborn assessment (routine)
MN21.4-V6-R26
- Peer review and update of literature and references
- Added: additional detail about newborn bloodspot screening
- Added: flowchart for critical congenital heart disease screening
26/11/2021
Establishing breastfeeding
MN21.19-V4-R26
- Peer review and update of literature and references
22/11/2021
Maternity care for mothers and babies during COVID-19 pandemic
MN21.63-V7-R26
- Full review and update of literature and references
- New: Flowchart Location and precautions if SCOVID or COVID-19, including rapid PCR testing
- New: Section Peripartum risk management with abbreviated and reordered infection prevention and control information
- New: Section Clinical course in pregnancy and postpartum
- New: Recommendations for ACE inhibitors, carboprost, tranexamic acid, low dose aspirin, delayed cord clamping, neonatal testing for COVID-19, neonatal administration of vitamin K, hepatitis B vaccine and immunoglobulin
- New: Information for neonatal supportive care
- Updated information: vaccination, organisation of neonatal unit
- Deleted: Flowchart Assessment of inpatient woman
- Deleted: Operational Framework
15/11/2021
Neonatal resuscitation
MN16.5-V5-R21
- Review date extended FROM Nov 2021 TO Dec 2022. Nil content changes
15/11/2021
Early onset Group B streptococcal disease
MN16.20-V4-R21